Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter-Paul Hekking

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2019
Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe AsthmaPieter-Paul Hekking, W Gerald Teague
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2017
Comorbidities in Difficult-to-Control AsthmaPieter-Paul Hekking, Marijke Amelink, Reinier R Wener, et al.
Respiration; International Review of Thoracic Diseases|September 18, 2021
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in AsthmaKatrien Eger, Marijke Amelink, Simone Hashimoto, et al.
Allergy|January 10, 2024
Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthmaPieter-Paul Hekking, Kayla Zhang, Carmen Paz Venegas Garrido, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2024
Severe COPD: Multidisciplinary Consultation to Get the Right Care at the Right PlacePieter-Paul Hekking, Monique van Meggelen, W Johan Lie, et al.
Allergy|October 12, 2018
Treatable traits in the European U-BIOPRED adult asthma cohortsAndrew J Simpson, Pieter-Paul Hekking, Dominick E Shaw, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 23, 2025
Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and ActivityLianne Ten Have, Karin B Fieten, Fleur L Meulmeester, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthmaPaul Brinkman, Ariane H Wagener, Pieter-Paul Hekking, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2019
Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe AsthmaPieter-Paul Hekking, W Gerald Teague
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2017
Comorbidities in Difficult-to-Control AsthmaPieter-Paul Hekking, Marijke Amelink, Reinier R Wener, et al.
Respiration; International Review of Thoracic Diseases|September 18, 2021
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in AsthmaKatrien Eger, Marijke Amelink, Simone Hashimoto, et al.
Allergy|January 10, 2024
Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthmaPieter-Paul Hekking, Kayla Zhang, Carmen Paz Venegas Garrido, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2024
Severe COPD: Multidisciplinary Consultation to Get the Right Care at the Right PlacePieter-Paul Hekking, Monique van Meggelen, W Johan Lie, et al.
Allergy|October 12, 2018
Treatable traits in the European U-BIOPRED adult asthma cohortsAndrew J Simpson, Pieter-Paul Hekking, Dominick E Shaw, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 23, 2025
Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and ActivityLianne Ten Have, Karin B Fieten, Fleur L Meulmeester, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthmaPaul Brinkman, Ariane H Wagener, Pieter-Paul Hekking, et al.
Pageof 1